5232072022-07-012022-09-305232072022-09-305232072022-03-315232072022-04-012022-09-305232072022-07-012022-09-30in-bse-fin:OtherExpenses1Member5232072022-04-012022-09-30in-bse-fin:OtherExpenses1Member5232072022-07-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15232072022-07-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25232072022-04-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15232072022-04-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares523207KOKUYOCMLNNAINE760A01029KOKUYO CAMLIN LIMITEDEquity2022-04-012023-03-312022-10-212022-10-11INRLakhsHalf yearlySingle segmentConsumer Products2022-10-2112:00:002022-10-2113:47:00trueCash Flow IndirectNot applicable2022-07-012022-09-30UnauditedStandalone18984690003660001898835000810650000404455000-4446500022971600083120004239700035141900018024840009635100009635100034590000234500005804000003831100000003831100010383000486940000010030400010.380.38000.380.38Notes: <BR> 1 The above results have been reviewed by the Audit Committee and approved by the Board of directors at their meeting held on 21 October 2022.The results have been subjected to a limited review by the Statutory Auditors of the Company who have expressed an unmodified conclusion thereon. <BR> 2 Figures of corresponding previous year's six months are not comparable due to impact of Covid 19 during that period. <BR> 3 The Company has revised its annual projections of taxable income and consequently also revised the estimate of the weighted average annual income tax rate expected for the full financial year. Accordingly, the Company has recorded current tax (after setting off carried forward losses) and deferred tax in the quarter and six months ended 30 September 2022. <BR> 4 The entire operations of the Company constitute a single operating segment i.e. "Consumer Products" as per Ind AS 108 "Operating segments" specified under section 133 of the Companies Act ,2013. <BR> <BR> 2022-04-012022-09-30UnauditedStandalone3860049000201300038620620001596685000836289000815100046090700019367000847230006760560003682178000179884000017988400034590000234500005804000001218440000000121844000-175560001042880000010030400011.211.21001.211.21Other Expenses351419000Other Expenses6760560001205310000273000027029000120032000037066000157098000243933000163364300013951350000601129000363400008338000064580700024891600022898580005916100039826620001003040002397989000249829300024982930002123700072000213090005799800020762000100069000375150000622967000230687000122880400012317000077360002459000013843000001484369000398266200019367000-124766000-57320000-4615100000-70500001475470000925340000847230000-3149000000-880000101500000002026000001645910003444750000001121900003332560000000000049000344880000000000000000000008450000-6223000-398170000000000003083320000001882300000-327155000-337160000-337160007005600036340000Remeasurement of net defined benefit plan-596000Fair value changes of equity instruments through other comprehensive income82910007695000Remeasurement of net defined benefit plan-3295000Fair value changes of equity instruments through other comprehensive income-16949000-20244000-2688000-268800000